Drug-labels.com

L01EF Cyclin-dependent kinase (CDK) inhibitors

ATC class of level 4 – chemical subgroup

This page lists the patient medication information or the product monograph for 7 drugs in this drug class and its subclasses.

Place in the ATC system

  1. L Antineoplastic and immunomodulating agents 1,069 drugs
    1. L01 Antineoplastic agents 616 drugs
      1. L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 118 drugs
        1. L01EF Cyclin-dependent kinase (CDK) inhibitors 7 drugs
          1. L01EF01 Palbociclib 5 drugs
          2. L01EF02 Ribociclib 1 drug
          3. L01EF03 Abemaciclib 1 drug

Active ingredients of the class

Drugs in the class and its subclasses

DrugRx or OTC
Ibrance (Pfizer Canada, Capsule) (L01EF01 Palbociclib) prescription (Rx)
Ibrance (Pfizer Canada, Tablet) PM (L01EF01 Palbociclib) prescription (Rx)
Kisqali PM (L01EF02 Ribociclib) prescription (Rx)
Nat-Palbociclib PM (L01EF01 Palbociclib) prescription (Rx)
PMS-Palbociclib PM (L01EF01 Palbociclib) prescription (Rx)
Taro-Palbociclib PM (L01EF01 Palbociclib) prescription (Rx)
Verzenio PM (L01EF03 Abemaciclib) prescription (Rx)

Other classes of the same level

Other names of the drug class

Sources

  • Patient medication information and product monographs: Health Canada, Drug Product Database
  • Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
  • World Health Organization (WHO): ATC/DDD system, class L01EF

Ask your doctor or pharmacist for advice.